Lexapro's Marketing Plan Shows How Drug Maker Pushes New Drugs

Lexapro's Marketing Plan Shows How Drug Maker Pushes New Drugs

The Senate just released 88 pages of a confidential 270+ page marketing plan by Forest Laboratories, created in 2004 and focused on how to get doctors to prescribe the antidepressant Lexapro over similar but cheaper alternatives such as Celexa. The New York Times notes that the line between marketing and education seems to be heavily blurred, which may not surprise you. There are, however, two interesting notes for consumers who may be taking Lexapro.